VAMP1

VAMP1 is a synaptic vesicle-associated v-SNARE that drives Ca2+-triggered neurotransmitter and hormone exocytosis across neuronal and secretory cell types (PMID:3380805, PMID:21282288). It is an integral membrane protein anchored by a hydrophobic C-terminus, with the bulk of the protein facing the cytoplasm where it engages the membrane-fusion machinery (PMID:3380805). At the neuromuscular junction VAMP1 plays an essential, non-redundant role: its loss reduces both spontaneous and evoked release, lowers initial release probability, and degrades the Ca2+ sensitivity and cooperativity of exocytosis without changing the size of the readily releasable pool (PMID:21282288). In secretory contexts VAMP1 assembles into SNARE complexes with syntaxin and SNAP-25 to mediate regulated exocytosis — driving ANP release from cardiac myocytes via complexes with syntaxin-4 (PMID:20801128) and CGRP release together with TRPV1/TRPA1 channel surface delivery in sensory neurons via syntaxin-1, SNAP-25, and Munc18-1, a process blocked by botulinum neurotoxins (PMID:26888187). VAMP1 is selectively expressed in GABAergic interneurons, where its mRNA is stabilized by RBFOX1 acting against microRNA-9 at the 3' UTR, linking VAMP1 abundance to inhibitory synaptic transmission and excitatory/inhibitory balance (PMID:29621484). C-terminal alternative splicing diversifies its targeting: the VAMP-1B isoform carries a shortened hydrophobic anchor plus added positive charge that redirects it to mitochondria, whereas VAMP-1A localizes to the plasma membrane and endosome-like structures (PMID:9658161). Loss of VAMP1 in mice causes severe neurological impairment and lethality, attributable principally to presynaptic neuronal loss (PMID:17102983, PMID:42244714).

1. 1988 High

   Established VAMP1 as a synaptic vesicle membrane protein with a defined topology, framing it as a candidate machinery component for neurotransmitter packaging, transport, or release.

   Evidence cDNA cloning from Torpedo electromotor nucleus and protease-protection (tryptic digestion of intact vs. lysed vesicles)

   PMID:3380805

   Open questions at the time

   • No fusion partners or SNARE complex identified at this stage
   • Functional role in release not yet tested
2. 1998 High

   Showed that C-terminal alternative splicing dictates VAMP1 organelle targeting, explaining how a single gene can serve both plasma-membrane/endosomal and mitochondrial localizations.

   Evidence Epitope-tagged isoform transfection in endothelial cells with C-terminal deletion/mutation analysis and fluorescence localization

   PMID:9658161

   Open questions at the time

   • Functional consequence of mitochondrial VAMP-1B localization not defined
   • Localization shown in heterologous endothelial cells, not neurons
3. 2006 High

   Demonstrated that VAMP1 is essential in vivo, with null mutation causing severe neurological deficits and lethality in specific CNS tissues.

   Evidence Positional cloning of the lethal-wasting mouse nonsense mutation with Western blot confirmation of protein absence

   PMID:17102983

   Open questions at the time

   • Cellular/synaptic mechanism of lethality not resolved
   • Tissue site driving the phenotype not pinpointed
4. 2010 High

   Defined a SNARE-mediated secretory role outside neurons, showing VAMP1 with syntaxin-4 mediates regulated ANP granule exocytosis, with isoform specificity (VAMP-3 dispensable).

   Evidence Co-sedimentation, co-localization, SNARE complex IP, and siRNA knockdown with ANP secretion assay in cardiac myocytes

   PMID:20801128

   Open questions at the time

   • Regulation of VAMP1/syntaxin-4 assembly not characterized
   • Relative contribution of VAMP1 vs VAMP2 not dissected
5. 2010 Medium

   Probed how lipid environment shapes VAMP1 conformation and orientation, indicating protein-lipid interactions modulate its membrane behavior.

   Evidence Lipid monolayer reconstitution with infrared spectroscopy and surface-pressure measurements in neutral vs anionic lipids

   PMID:20085749

   Open questions at the time

   • Biophysical reconstitution only; no in-cell validation
   • Relevance to SNARE function not established
6. 2011 High

   Resolved the synaptic mechanism of VAMP1, showing it is non-redundant for Ca2+ sensitivity and cooperativity of release at the NMJ rather than for vesicle pool maintenance.

   Evidence Multi-parameter electrophysiology (evoked/spontaneous release, paired-pulse facilitation, Ca2+ dose-response) in Syb1 null mice

   PMID:21282288

   Open questions at the time

   • Molecular basis for the Ca2+ sensitivity defect not defined
   • Whether other VAMPs compensate not addressed here
7. 2014 Medium

   Identified transcriptional control of VAMP1 by calcineurin/NFAT downstream of PMCA, linking Ca2+ pump activity to SNARE abundance and secretion.

   Evidence PMCA2/3 knockdown, NFAT activation assays, ChIP at Vamp loci, and dopamine secretion assay in PC12 cells

   PMID:24667359

   Open questions at the time

   • Single cell line; in vivo relevance untested
   • Direct vs indirect NFAT regulation not fully resolved
8. 2016 High

   Extended VAMP1's role to sensory-neuron secretion and channel trafficking, showing isoform-specific control of CGRP release and TNFα-induced TRPV1/TRPA1 surface delivery via syntaxin-1/SNAP-25/Munc18-1.

   Evidence Isoform-selective siRNA, surface biotinylation, BoNT cleavage, CGRP ELISA, and Ca2+ influx in sensory neurons

   PMID:26888187

   Open questions at the time

   • Direct VAMP1-channel association vs SNARE-dependent trafficking not separated
   • Mechanism coupling TNFα signaling to VAMP1-dependent trafficking unknown
9. 2018 High

   Connected VAMP1 to inhibitory circuit function and an upstream RNA regulatory axis, showing RBFOX1 stabilizes Vamp1 mRNA against miR-9 to maintain GABAergic transmission and E/I balance.

   Evidence 3'UTR/RNA-binding and miR-9 blocking assays, Vamp1 knockdown, and interneuron-selective rescue in Rbfox1 cKO mice with electrophysiology

   PMID:29621484

   Open questions at the time

   • Whether RBFOX1-VAMP1 axis operates in other neuron classes not addressed
   • Quantitative contribution of miR-9 vs other regulators unresolved
10. 2026 High

    Pinpointed the lethal VAMP1-null phenotype to presynaptic neuronal loss and showed VAMP2 can functionally substitute for VAMP1 at motor terminals in vivo.

    Evidence Neuron-specific ECFP-Syb2 transgenic rescue of Syb1 null mice with NMJ electrophysiology and behavioral/growth readouts (preprint)

    PMID:42244714

    Open questions at the time

    • Preprint; not yet peer-reviewed
    • Whether substitution holds at non-NMJ synapses not tested
    • Does not explain why VAMP1 is selectively used at certain synapses

• The functional role of mitochondrially targeted VAMP-1B and the structural basis of VAMP1's reduced Ca2+ cooperativity relative to other VAMPs remain unresolved.
• No assigned function for the mitochondrial VAMP-1B isoform
• No structural model explaining isoform-specific Ca2+ sensitivity at synapses